GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , leading to reduced caloric intake and weight loss Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus [oral form]), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
Research has shown the weight loss benefits of semaglutide injections in individuals without diabetes
Many of these drugs are being prescribed for weight loss for patients who are not obese or with weight- related medical problems
Anatomopathological examination is nonspecific and aims to exclude other tumor diagnoses, with heterogeneous microscopy findings of a high mitotic index, nuclear atypia, necrosis, and hemorrhage being common
Miljana Nikolicvery juicyApril 2, 2026its really paaacked with the essence
To keep on working, patients may need to keep taking them indefinitely